NewsBenzingaRoche erweitert seine Alzheimer-Pipeline mit neuer Phase-II-Studie TARBELA-AD zum oralen NLRP3-Inhibitor RG6434 und wird auf der CTAD vom 16. bis 19. November Daten zu Trontinemab, PrevenTRON und dem Elecsys-Bluttest vorstellen Roche erweitert seine Alzheimer-Pipeline mit neuer Phase-II-Studie TARBELA-AD zum oralen NLRP3-Inhibitor RG6434 und wird auf der CTAD vom 16. bis 19. November Daten zu Trontinemab, PrevenTRON und dem Elecsys-Bluttest vorstellen Benzinga 2026.11.10 06:25 (GMT+0) Open on Benzinga Other news Peter Schiff Says AI Stocks Aren’t the ‘Only Bubble’ Out There: The Economist Predicts All Will ‘Deflate,’ but Prediction Market Isn’t Buying It Taiwan Semiconductor (TSM) Stock Trending After Nvidia Posts Strong Q3 Results: What You Should Know ‘Not the Nvidia I Know’: Jim Cramer Questions Employee Morale; Colette Kress Has ‘High Confidence’ Staff Still ‘Enjoy’ Their Work Bitcoin, Ethereum Dip, While XRP, Dogecoin Gain as US Launches 'Self-Defense' Strikes Against Iran: Analyst Asks BTC Investors to 'Endure' Next 2 Months of Pain Jeff Bezos Warns Outsider CEO Replacing Jensen Huang Faces ‘Vanishingly Small Chance of Succeeding’ at Nvidia: ‘Too Complicated’ Nvidia, Salesforce, Nebius Group, Applied Optoelectronics and Nike: Why These 5 Stocks Are on Investors' Radars Today
Peter Schiff Says AI Stocks Aren’t the ‘Only Bubble’ Out There: The Economist Predicts All Will ‘Deflate,’ but Prediction Market Isn’t Buying It
‘Not the Nvidia I Know’: Jim Cramer Questions Employee Morale; Colette Kress Has ‘High Confidence’ Staff Still ‘Enjoy’ Their Work
Bitcoin, Ethereum Dip, While XRP, Dogecoin Gain as US Launches 'Self-Defense' Strikes Against Iran: Analyst Asks BTC Investors to 'Endure' Next 2 Months of Pain
Jeff Bezos Warns Outsider CEO Replacing Jensen Huang Faces ‘Vanishingly Small Chance of Succeeding’ at Nvidia: ‘Too Complicated’
Nvidia, Salesforce, Nebius Group, Applied Optoelectronics and Nike: Why These 5 Stocks Are on Investors' Radars Today